TGF-βs ACTIVATE CELL DEATH IN MCF-7 CELLS AFTER TREATMENT WITH GEMCITABINE OR 5-FU THROUGH THE SYNERGISTIC COLLABORATION OF SMAD SIGNALING PATHWAYS